Ellenoff Grossman & Schole, LLP
1354 Avenue of the Americas, 11th Floor
New York, New York 10105-0302
December 13, 2013
VIA EDGAR
Mr. Jeffrey Riedler
Assistant Director
Division of Corporate Finance
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Re: | BioDelivery Sciences International, Inc. Registration Statement on Form S-3 Filed November 29, 2013 File No. 333-192618
|
Dear Mr. Riedler:
On behalf of BioDelivery Sciences International, Inc. (the “Company”), we are electronically transmitting hereunder a copy of Amendment No. 1 to Form S-3 (the “Amendment”) filed by the Company with the Securities and Exchange Commission (the “Commission”) on December 13, 2013 together with this letter.
This letter responds to the Staff’s comments set forth in a letter dated December 12, 2013, with respect to our Registration Statement on Form S-3 filed with the Commission on November 29, 2013 (File No. 333-192618). In this letter, we have recited the comment from the Staff in bold and have followed such comment with the Company’s response.
1. | On both pages 13 and SA-16, please incorporate by reference the Current Report on Form 8-K filed on December 2, 2013. |
In response to the Staff’s comment, the Company has updated the incorporation by reference to include reference to theForm 8-K filed on December 2, 2013. Please note that the Company has made reference to the subject matter of its December 2, 2013Form 8-K in the two prospectus summary sections included in the Amendment.
If you have any questions or concerns, please contact me via telephone at (212) 370-1300 or via facsimile at (212) 370-7889.
Very truly yours, |
/s/ Lawrence A. Rosenbloom |
Lawrence A. Rosenbloom, Esq. |
cc: | BioDelivery Sciences International, Inc.. |